← Evidence map

TrialNature2019

The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity.

Jude Canon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1,331 papers cite itlatest 60 shown

2019
…
2026
this paperpooled itcites it

4 trials

Full record →Abstract, authors, funding and every citing paper · PMID 31666701